SecBot SecBot
6-K ·Filed Sep 22, 2026

CLGN

CollPlant Biotechnologies Ltd
NEUTRAL
Impact 3/10
Horizonimmediate Processed1mo ago SEC0001213900-26-102033
Notable filing: 6-K
Actionable Insight • Neutral

Nasdaq compliance removes a binary overhang, but the filing provides no financial data or operational catalyst. Monitor upcoming quarterly filings for revenue and cash runway from the rhCollagen and LightSolver segments.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
CLGN ▲ +0.78% at T+20d
NEUTRAL call +0.78% · α vs SPY +1.34% · entry $3.85 → $3.88
Next anchor: T+60d in 7w
Latest observation: T+23 -5.90% FF3 residual α
Entry = T+0 close
Sep 22, 2026
via day close
T+1d
+4.94%
call +4.94% · α +5.66%
$4.04
settled 5w ago
T+5d
-1.56%
call -1.56% · α -0.37%
$3.79
settled 28d ago
T+20d
+0.78%
call +0.78% · α +1.34%
$3.88
settled 7d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

CollPlant Biotechnologies announced it regained compliance with Nasdaq's minimum bid price requirement, closing a deficiency notice from March 2026. The stock closed at or above $1.00 for ten consecutive days through September 18, 2026, removing delisting risk. This is a routine administrative milestone with no financial data or operational catalyst.

Key Facts

  • Received Nasdaq deficiency notice on March 23, 2026 for bid price below $1.00
  • Closing bid price was at or above $1.00 for ten consecutive business days from September 4 to September 18, 2026
  • Nasdaq confirmed compliance with Listing Rule 5550(a)(2) and closed the matter
  • Press release references recent completion of LightSolver acquisition and strategic expansion into photonic computing

Financial Impact

No financial figures disclosed; delisting risk removed but no revenue, earnings, or cash impact quantified

Risk Factors

  • No financial data provided; business fundamentals and cash position remain unknown
  • Forward-looking statements about LightSolver and rhCollagen are aspirational with no near-term revenue visibility

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001213900-26-102033
Document: ea030619401ex99-1.htm0001213900-26-102033
Document: 0001213900-26-102033-index-headers.html0001213900-26-102033
Document: 0001213900-26-102033-index.html0001213900-26-102033
Document: 0001213900-26-102033.txt0001213900-26-102033
21 reports for CLGN
Performance horizon
100% Hit rate @ T+1 9 of 9 directional calls Went positive at some point 9 of 9 best @ T+60▲ +25.17%May 29, 2026
Filters
Rows
Reports for CLGN — sortable, filterable
TypeNow
Oct 27, 2026
today
144
NEUTRAL ★ 2/10
$3.78awaiting T+1—$3.90 (+3.17%)
Oct 19, 2026
8d ago
3
NEUTRAL ★ 2/10
$3.88 $3.76▼ −3.22%▼ −3.75%$3.90 (+0.52%)
Oct 15, 2026
12d ago
6-K
BEARISH ★ 6/10
$3.68 $3.63▲ +1.49%▲ +0.39%$3.90 (−5.98%)
Oct 9, 2026
18d ago
6-K
BEARISH ★ 5/10
$4.02 $3.91▲ +2.74%▲ +2.72%$3.90 (+2.99%)
Oct 8, 2026
19d ago
SC 13G
NEUTRAL ★ 3/10
$3.97 $3.51▼ −11.59%▼ −12.19%$3.90 (−1.76%)
Oct 8, 2026
19d ago
SC 13D/A
NEUTRAL ★ 3/10
$3.97 $3.51▼ −11.59%▼ −12.19%$3.90 (−1.76%)
Oct 6, 2026
21d ago
6-K
NEUTRAL ★ 3/10
$3.39 $3.46▲ +2.06%▲ +2.30%$3.90 (+15.04%)
Sep 30, 2026
27d ago
6-K
BEARISH ★ 7/10
$3.57 $3.46▲ +3.08%▲ +3.82%$3.90 (−9.24%)
Sep 30, 2026
27d ago
Press Release
BEARISH ★ 5/10
$3.57 $3.46▲ +3.08%▲ +3.82%$3.90 (−9.24%)
Sep 24, 2026
4w ago
6-K
NEUTRAL ★ 4/10
$4.12 $4.25▲ +3.16%▲ +2.61%$3.90 (−5.34%)
Showing 10 of 21

US Market Status

Market Closed — Opens Wed (15h 34m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 22, 2026